{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:38:25Z","timestamp":1794627505917,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Research Project of Anhui Province","award":["2022AH040161"],"award-info":[{"award-number":["2022AH040161"]}]},{"name":"University Research Project of Anhui Province","award":["2025AHGXZK40773"],"award-info":[{"award-number":["2025AHGXZK40773"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303475"],"award-info":[{"award-number":["82303475"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province","award":["IMMDL202406)"],"award-info":[{"award-number":["IMMDL202406)"]}]},{"name":"Quality Enhancement Project for New Era Education of Education Department of Anhui Province","award":["2024zyxwjxalk048"],"award-info":[{"award-number":["2024zyxwjxalk048"]}]},{"name":"National Health Commission Capacity Building and Continuing Education Center","award":["GWJJMB202510022056"],"award-info":[{"award-number":["GWJJMB202510022056"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The KRAS\n                      <jats:sup>G12C<\/jats:sup>\n                      mutation is one of the special mutation types in patients with colorectal cancer liver metastasis (CRLM). Although several small molecule inhibitors specifically targeting KRAS\n                      <jats:sup>G12C<\/jats:sup>\n                      mutation have been developed, they have only shown limited clinical benefits for CRLM patients. Thus, alternative approaches are still needed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We screened out the differentially expressed gene Aldo\u2013keto reductase family 1 member B10 (AKR1B10) between the KRAS\n                      <jats:sup>G12C<\/jats:sup>\n                      mutation and wild-type CRLM through RNA sequencing, and characterized the tumor microenvironment (TME) changes of the KRAS\n                      <jats:sup>G12C<\/jats:sup>\n                      mutation CRLM using multi-omics analysis.\u00a0The role of AKR1B10 in the TME and its progression of KRAS\n                      <jats:sup>G12C<\/jats:sup>\n                      mutation CRLM was confirmed by in vitro and in vivo experiments, and the molecular mechanism of lactate on neutrophils reprogramming was detected by immunofluorescence, western blot and Chip-qPCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AKR1B10 was highly expressed in the KRAS\n                      <jats:sup>G12C<\/jats:sup>\n                      mutation CRLM and was associated with a poor prognosis. Mechanistically, AKR1B10 promotes the recruitment of neutrophils in the TME by CXCL8\/CXCR2 pathway. Meanwhile, AKR1B10 could promote the production of lactate by regulating crucial glycolytic enzymes.\u00a0The increased lactate accumulation in the TME promoted histone lactylation of neutrophils, which induced PD-L1 transcription and prompted the reprogramming of neutrophils to an immunosuppressive phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      AKR1B10 facilitated immune evasion of KRAS\n                      <jats:sup>G12C<\/jats:sup>\n                      mutation CRLM by recruiting and reprogramming neutrophils to remodel the immunosuppressive TME, providing a potential therapeutic target for KRAS\n                      <jats:sup>G12C<\/jats:sup>\n                      mutation CRLM patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03653-2","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T03:06:42Z","timestamp":1770088002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["AKR1B10 reprograms neutrophils by histone lactylation to foster immune evasion in KRASG12C mutation colorectal cancer liver metastasis"],"prefix":"10.1186","volume":"45","author":[{"given":"Weiwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canliang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieliang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"3653_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3653_CR2","doi-asserted-by":"crossref","unstructured":"Chandra R, Karalis JD, Liu C, Murimwa GZ, Voth Park J, Heid CA, et al. The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis. Cancers. 2021;13(24):6206.","DOI":"10.3390\/cancers13246206"},{"key":"3653_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-021-01441-4","volume":"20","author":"G Zhu","year":"2021","unstructured":"Zhu G, Pei L, Xia H, Tang Q, Bi F. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer. 2021;20:143.","journal-title":"Mol Cancer"},{"key":"3653_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2022.01.012","volume":"168","author":"FE Buisman","year":"2022","unstructured":"Buisman FE, Giardiello D, Kemeny NE, Steyerberg EW, H\u00f6ppener DJ, Galjart B, et al. Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment. Eur J Cancer (Oxford, England\u202f: 1990). 2022;168:25\u201333.","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"key":"3653_CR5","first-page":"e2203757","volume":"10","author":"H Liu","year":"2023","unstructured":"Liu H, Liang Z, Cheng S, Huang L, Li W, Zhou C, et al. Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T-Cells to Activation-Induced Cell Death in Colorectal Cancer. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2023;10:e2203757.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)."},{"key":"3653_CR6","first-page":"189382","volume":"1880","author":"G Zhu","year":"2025","unstructured":"Zhu G, Pei L, Ye D, Tang Q, Xu H, Bi F. Targeting KRAS in colorectal cancer immunotherapy: rationale, challenges and future directions. Biochim Biophys Acta. 2025;1880:189382.","journal-title":"Biochim Biophys Acta"},{"key":"3653_CR7","doi-asserted-by":"publisher","first-page":"200786","DOI":"10.1016\/j.omton.2024.200786","volume":"32","author":"E Lou","year":"2024","unstructured":"Lou E, Xiu J, Baca Y, Saeed A, Prakash A, Gholami S, et al. Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers. Mol Ther Oncolytics. 2024;32:200786.","journal-title":"Mol Ther Oncolytics"},{"key":"3653_CR8","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.7150\/ijbs.88779","volume":"20","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Kuang Y, Wang C, Yu Y, Pan L, Hu X. Impact of KRAS mutation on the tumor microenvironment in colorectal cancer. Int J Biol Sci. 2024;20:1947\u201364.","journal-title":"Int J Biol Sci"},{"key":"3653_CR9","doi-asserted-by":"crossref","unstructured":"Zhang C, Wang XY, Zuo JL, Wang XF, Feng XW, Zhang B, et al. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases. J Immunother Cancer. 2023;11(2):e006425.","DOI":"10.1136\/jitc-2022-006425"},{"key":"3653_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/hep.30166","volume":"69","author":"C Haider","year":"2019","unstructured":"Haider C, Hnat J, Wagner R, Huber H, Timelthaler G, Grubinger M, et al. Transforming growth factor-\u03b2 and Axl induce CXCL5 and neutrophil recruitment in hepatocellular carcinoma. Hepatology (Baltimore, MD). 2019;69:222\u201336.","journal-title":"Hepatology (Baltimore, MD)"},{"key":"3653_CR11","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1136\/gutjnl-2016-313075","volume":"66","author":"TT Wang","year":"2017","unstructured":"Wang TT, Zhao YL, Peng LS, Chen N, Chen W, Lv YP, et al. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut. 2017;66:1900\u201311.","journal-title":"Gut"},{"key":"3653_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41590-024-02029-y","volume":"26","author":"E Eruslanov","year":"2025","unstructured":"Eruslanov E, Nefedova Y, Gabrilovich DI. The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting. Nat Immunol. 2025;26:17\u201328.","journal-title":"Nat Immunol"},{"key":"3653_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00384-024-04800-x","volume":"40","author":"XY Wang","year":"2025","unstructured":"Wang XY, Zuo JL, Fu H, Zhang C, Fan QQ, Zhang B, et al. The impact of neoadjuvant therapy on the prognostic value of preoperative neutrophil-to-lymphocyte ratio for colorectal liver metastases: a multi-center cohort study. Int J Colorectal Dis. 2025;40:10.","journal-title":"Int J Colorectal Dis"},{"key":"3653_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1021\/acs.jmedchem.4c01116","volume":"68","author":"R Maccari","year":"2025","unstructured":"Maccari R, Ottan\u00e0 R. In search for inhibitors of human Aldo-Keto reductase 1B10 (AKR1B10) as novel agents to fight cancer and chemoresistance: current state-of-the-art and prospects. J Med Chem. 2025;68:860\u201385.","journal-title":"J Med Chem"},{"key":"3653_CR15","doi-asserted-by":"publisher","first-page":"1462174","DOI":"10.3389\/fimmu.2024.1462174","volume":"15","author":"Y Shen","year":"2024","unstructured":"Shen Y, Qiu A, Huang X, Wen X, Shehzadi S, He Y, et al. AKR1B10 and digestive tumors development: a review. Front Immunol. 2024;15:1462174.","journal-title":"Front Immunol"},{"key":"3653_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.canlet.2014.09.031","volume":"355","author":"W Zhang","year":"2014","unstructured":"Zhang W, Li H, Yang Y, Liao J, Yang GY. Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway. Cancer Lett. 2014;355:273\u201380.","journal-title":"Cancer Lett"},{"key":"3653_CR17","doi-asserted-by":"publisher","first-page":"e0279591","DOI":"10.1371\/journal.pone.0279591","volume":"17","author":"Z Wang","year":"2022","unstructured":"Wang Z, Pei Y, Li W, Zhang J, Liu J. Clinical value of AKR1B10 in hepatocellular carcinoma: a systematic review and meta-analysis. PLoS One. 2022;17:e0279591.","journal-title":"PLoS One"},{"key":"3653_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12935-022-02809-2","volume":"22","author":"J Cai","year":"2022","unstructured":"Cai J, Cui Z, Zhou J, Zhang B, Lu R, Ding Y, et al. Mettl3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10. Cancer Cell Int. 2022;22:385.","journal-title":"Cancer Cell Int"},{"key":"3653_CR19","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1158\/1078-0432.CCR-23-3980","volume":"30","author":"KN Suvilesh","year":"2024","unstructured":"Suvilesh KN, Manjunath Y, Nussbaum YI, Gadelkarim M, Raju M, Srivastava A, et al. Targeting AKR1B10 by drug repurposing with Epalrestat overcomes chemoresistance in non-small cell lung cancer patient-derived tumor organoids. Clin Cancer Res. 2024;30:3855\u201367.","journal-title":"Clin Cancer Res"},{"key":"3653_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10735-022-10093-7","volume":"53","author":"C Liu","year":"2022","unstructured":"Liu C, Shi L, Li W, Huang Z, Wang S, Xu P, et al. AKR1B10 accelerates the production of proinflammatory cytokines via the NF-\u03baB signaling pathway in colon cancer. J Mol Histol. 2022;53:781\u201391.","journal-title":"J Mol Histol"},{"key":"3653_CR21","doi-asserted-by":"publisher","first-page":"114185","DOI":"10.1016\/j.ejca.2024.114185","volume":"207","author":"J Michiel Zeeuw","year":"2024","unstructured":"Michiel Zeeuw J, Wesdorp NJ, Ali M, Bakker AJJ, Voigt KR, Starmans MPA, et al. Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation. Eur J Cancer (Oxford, England\u202f: 1990). 2024;207:114185.","journal-title":"Eur J Cancer (Oxford, England : 1990)."},{"key":"3653_CR22","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.7150\/ijbs.104079","volume":"21","author":"Q Liu","year":"2025","unstructured":"Liu Q, Liu Z, Zhang X, Zeng A, Song L. Revisiting of cancer immunotherapy: insight from the dialogue between glycolysis and PD-1\/PD-L1 axis in the tumor microenvironment. Int J Biol Sci. 2025;21:1202\u201321.","journal-title":"Int J Biol Sci"},{"key":"3653_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12967-023-04403-0","volume":"21","author":"W Duan","year":"2023","unstructured":"Duan W, Liu W, Xia S, Zhou Y, Tang M, Xu M, et al. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. J Transl Med. 2023;21:547.","journal-title":"J Transl Med"},{"key":"3653_CR24","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","volume":"72","author":"T Fiaschi","year":"2012","unstructured":"Fiaschi T, Marini A, Giannoni E, Taddei ML, Gandellini P, De Donatis A, et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Can Res. 2012;72:5130\u201340.","journal-title":"Can Res"},{"key":"3653_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"3653_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s12276-025-01410-7","volume":"57","author":"H Rho","year":"2025","unstructured":"Rho H, Hay N. Protein lactylation in cancer: mechanisms and potential therapeutic implications. Exp Mol Med. 2025;57:545\u201353.","journal-title":"Exp Mol Med"},{"key":"3653_CR27","first-page":"e2204097","volume":"9","author":"S Mo","year":"2022","unstructured":"Mo S, Tang P, Luo W, Zhang L, Li Y, Hu X, et al. Patient-derived organoids from colorectal cancer with paired liver metastasis reveal tumor heterogeneity and predict response to chemotherapy. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2022;9:e2204097.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"3653_CR28","doi-asserted-by":"crossref","unstructured":"Isermann T, Sers C, Der CJ, Papke B. KRAS inhibitors: resistance drivers and combinatorial strategies. Trends Cancer. 2025;11(2):91\u2013116.","DOI":"10.1016\/j.trecan.2024.11.009"},{"key":"3653_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13046-025-03369-9","volume":"44","author":"J Wu","year":"2025","unstructured":"Wu J, Xie K, Zhang Y, Zhang W, Cheng R, Zhang Y, et al. RASON promotes KRAS(G12C)-driven tumor progression and immune evasion in non-small cell lung cancer. J Exp Clin Cancer Res. 2025;44:106.","journal-title":"J Exp Clin Cancer Res"},{"key":"3653_CR30","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","volume":"383","author":"DS Hong","year":"2020","unstructured":"Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, et al. KRAS(G12C) inhibition with sotorasib in advanced solid tumors. N Engl J Med. 2020;383:1207\u201317.","journal-title":"N Engl J Med"},{"key":"3653_CR31","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00535-023-02011-9","volume":"58","author":"C Xie","year":"2023","unstructured":"Xie C, Ye X, Zeng L, Zeng X, Cao D. Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma. J Gastroenterol. 2023;58:1030\u201342.","journal-title":"J Gastroenterol"},{"key":"3653_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/curroncol30010007","volume":"30","author":"YY Liu","year":"2022","unstructured":"Liu YY, Liu YW, Huang GK, Hung KC, Lin YH, Yeh CH, et al. Overexpression of AKR1B10 predicts poor prognosis in gastric cancer patients undergoing surgical resection. Current oncology (Toronto, Ont). 2022;30:85\u201399.","journal-title":"Current oncology (Toronto, Ont)"},{"key":"3653_CR33","doi-asserted-by":"publisher","first-page":"eadv6937","DOI":"10.1126\/sciadv.adv6937","volume":"11","author":"X Wu","year":"2025","unstructured":"Wu X, Huang S, Gao J, Huang S, Chen L, Zhao Z, et al. AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration. Sci Adv. 2025;11:eadv6937.","journal-title":"Sci Adv"},{"key":"3653_CR34","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1111\/febs.15612","volume":"288","author":"A Klimpel","year":"2021","unstructured":"Klimpel A, Stillger K, Wiederstein JL, Kr\u00fcger M, Neundorf I. Cell-permeable CaaX-peptides affect K-Ras downstream signaling and promote cell death in cancer cells. FEBS J. 2021;288:2911\u201329.","journal-title":"FEBS J"},{"key":"3653_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-021-00375-9","volume":"21","author":"SA Kerk","year":"2021","unstructured":"Kerk SA, Papagiannakopoulos T, Shah YM, Lyssiotis CA. Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment. Nat Rev Cancer. 2021;21:510\u201325.","journal-title":"Nat Rev Cancer"},{"key":"3653_CR36","doi-asserted-by":"crossref","unstructured":"Deng H, Kan A, Lyu N, He M, Huang X, Qiao S, et al. Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma. J Immunother Cancer. 2021;9(6):e002305.","DOI":"10.1136\/jitc-2020-002305"},{"key":"3653_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1158\/2326-6066.CIR-22-0595","volume":"11","author":"P Xu","year":"2023","unstructured":"Xu P, Zhang X, Chen K, Zhu M, Jia R, Zhou Q, et al. Tumor cell-derived microparticles induced by methotrexate augment T-cell antitumor responses by downregulating expression of PD-1 in neutrophils. Cancer Immunol Res. 2023;11:501\u201314.","journal-title":"Cancer Immunol Res"},{"key":"3653_CR38","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-24-4394","volume":"85","author":"Z Zong","year":"2025","unstructured":"Zong Z, Zhang L, Zhou F. Lactylation in cancer: advances, challenges, and future perspectives. Cancer Res. 2025;85:3192\u20135.","journal-title":"Cancer Res"},{"key":"3653_CR39","doi-asserted-by":"crossref","unstructured":"Hou X, Hong Z, Zen H, Zhang C, Zhang P, Ma D, et al. Lactylation in cancer biology: Unlocking new avenues for research and therapy. Cancer Commun (London, England). 2025;45(11):1367\u2013406.","DOI":"10.1002\/cac2.70054"},{"key":"3653_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, Sun YX, et al. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther. 2023;8:391.","journal-title":"Signal Transduct Target Ther"},{"key":"3653_CR41","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41419-025-07482-7","volume":"16","author":"CH Ding","year":"2025","unstructured":"Ding CH, Yan FZ, Xu BN, Qian H, Hong XL, Liu SQ, et al. PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma. Cell Death Dis. 2025;16:158.","journal-title":"Cell Death Dis"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03653-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:08:26Z","timestamp":1772582906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03653-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3653"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03653-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was provided by all patients, and the Ethical Committee of the First Affiliated Hospital of Anhui Medical University (Anhui, China) (approval number: Quick-PJ 2022\u201314-33) and Huashan Hospital Fudan University (Shanghai, China) (approval number: KY2022-946). All mouse experiments were approved by the Animal Ethics Committee of Anhui Medical University (approval number: LLSC-20230579).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed with publishing this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}